These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3927838)

  • 21. Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.
    Akbergenov R; Shcherbakov D; Matt T; Duscha S; Meyer M; Wilson DN; Böttger EC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4712-7. PubMed ID: 21768509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance system of Mycobacterium bovis B.C.B. to aminoglycoside- and peptide-antibiotics. Comparison of resistant phenotypes between Mycobacterium tuberculosis and Mycobacterium bovis.
    Tsukamura M
    Microbiol Immunol; 1980; 24(1):11-9. PubMed ID: 6153747
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
    Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C
    J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait and Dubai.
    Ahmad S; Mokaddas E; Fares E
    Diagn Microbiol Infect Dis; 2002 Nov; 44(3):245-52. PubMed ID: 12493171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.
    Berrada ZL; Lin SY; Rodwell TC; Nguyen D; Schecter GF; Pham L; Janda JM; Elmaraachli W; Catanzaro A; Desmond E
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):177-81. PubMed ID: 27036978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of antibiotic resistance in Mycobacterium intracellulare.
    Mizuguchi Y; Udou T; Yamada T
    Microbiol Immunol; 1983; 27(5):425-31. PubMed ID: 6312275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of compensatory mutations in the rpoC gene and their association with compensated transmission of Mycobacterium tuberculosis.
    Wang S; Zhou Y; Zhao B; Ou X; Xia H; Zheng Y; Song Y; Cheng Q; Wang X; Zhao Y
    Front Med; 2020 Feb; 14(1):51-59. PubMed ID: 31938981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-resistance test for kanamycin and cross resistance problem in Mycobacterium tuberculosis with special reference to kanamycin, streptomycin, and viomycin.
    TSUKAMURA M
    J Antibiot (Tokyo); 1959 Jul; 12():189-91. PubMed ID: 13855139
    [No Abstract]   [Full Text] [Related]  

  • 30. The susceptibility of mycobacteria to rifamide and rifampicin.
    Clark J; Wallace A
    Tubercle; 1967 Jun; 48(2):144-8. PubMed ID: 4293697
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibacterial activity of palmitoyltuberactinamine N and di-beta-lysylcapreomycin IIA.
    Yamada T; Yamanouchi T; Ono Y; Nagata A; Wakamiya T; Teshima T; Shiba T
    J Antibiot (Tokyo); 1983 Dec; 36(12):1729-34. PubMed ID: 6198315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis.
    Morris S; Bai GH; Suffys P; Portillo-Gomez L; Fairchok M; Rouse D
    J Infect Dis; 1995 Apr; 171(4):954-60. PubMed ID: 7706824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible Binding of Piperine in Mycobacterium tuberculosis RNA Polymerase and Rifampin Synergism.
    Murase LS; Perez de Souza JV; Meneguello JE; Seixas FAV; Hegeto LA; Scodro RBL; Siqueira VLD; Caleffi Ferracioli KR; Cardoso RF
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid determination of rifampin resistance in clinical isolates of Mycobacterium tuberculosis by real-time PCR.
    Kocagoz T; Saribas Z; Alp A
    J Clin Microbiol; 2005 Dec; 43(12):6015-9. PubMed ID: 16333091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STUDIES ON CROSS-RESISTANCE BETWEEN CAPREOMYCIN AND CERTAIN OTHER ANTI-MYCOBACTERIAL AGENTS.
    KOSEKI Y; OKAMOTO S
    Jpn J Med Sci Biol; 1963 Feb; 16():31-8. PubMed ID: 14044251
    [No Abstract]   [Full Text] [Related]  

  • 37. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.
    Brandis G; Pietsch F; Alemayehu R; Hughes D
    J Antimicrob Chemother; 2015 Mar; 70(3):680-5. PubMed ID: 25362573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Jnawali HN; Hwang SC; Park YK; Kim H; Lee YS; Chung GT; Choe KH; Ryoo S
    Diagn Microbiol Infect Dis; 2013 Jun; 76(2):187-96. PubMed ID: 23561273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual actions of viomycin on the ribosomal functions.
    Liou YF; Tanaka N
    Biochem Biophys Res Commun; 1976 Jul; 71(2):477-83. PubMed ID: 183772
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system.
    Taniguchi H; Chang B; Abe C; Nikaido Y; Mizuguchi Y; Yoshida SI
    J Bacteriol; 1997 Aug; 179(15):4795-801. PubMed ID: 9244267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.